Southeast Asia Olmesartan Market was valued at US$ 335.2 million in 2023 and is projected to surpass a valuation of US$ 518.8 million by 2032 at a CAGR of 4.3% during the forecast period 2024–2032.

Introduction Wearable cardioverter-defibrillators (WCD) have emerged as a valuable tool in the management of patients at risk ...

The global diabetic nephropathy market revenue was around US$ 2.0 billion in 2022 and is estimated to reach US$ 3.3 billion by 2031, growing at a compound annual growth rate (CAGR) of 6% during the ...

Curatis Holding (SIX:CURN) reports revenues of CHF 2.0m for H1 2024, whereby Curatis AG is only included for 2 months. Curatis AG was able to increase sales in the distribution business by 31% per ...

Credit: Marlissa Collier Plagued with an issue that has led to a prevalence of chronic disease and lower ... Anywhere you find this level of heart disease, hypertension, things like that, that are ...

The prevalence of hypertension is 22.7 percent among young adults aged 18 to 39 years and 5.4 percent among youth aged 8 to 19 years.

The survey highlighted differences in disease prevalence across age groups and regions. Among those aged 31 to 50 in urban and peri-urban areas, 32% had hypertension, compared to 22.9% in rural areas.

70.8% of those who were aware of their hypertension status and met criteria for meds had uncontrolled hypertension ...

A self-reported history of gestational hypertension is associated with cardiovascular disease (CVD) in postmenopausal women, ...

Sep. 5, 2024 — Over-the-counter blood pressure measuring devices offer a simple, affordable way for people to track hypertension at home, but the standard arm-size ranges for these devices won't ...

Hypertension (HTN) increases the risk of development of HF and it precedes it in 75% of cases. HF patients are nearly evenly divided between those with reduced left ventricular (LV) function or ...